Pancreatic islet-specific overexpression of Reg3β protein induced the expression of pro-islet genes and protected the mice against streptozotoc in induced diabetes mellitus

American Journal of Physiology - Endocrinology and Metabolism

Volumn 300, Issue 4, 2011, Pages 669-680

  Xiong, Xiaoquan ^a   Wang, Xiao ^a,b   Li, Bing ^a   Chowdhury, Subrata ^a   Lu, Yarong ^a   Srikant, Coimbatore B ^a   Ning, Guang ^a,b   Liu, Jun Li ^a,c  

^a ROYAL VICTORIA HOSPITAL   (Canada)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c Montreal Diabetes Research Centre   (Canada)

Author keywords

DNA microarray; Immunofluorescence; Pancreatitis associated protein; Real time polymerase chain reaction; Reg family proteins; Transgenic mice; Western blot

Indexed keywords

GLUCOSE TRANSPORTER 2; OSTEOPONTIN; PANCREATITIS ASSOCIATED PROTEIN; PROTEIN P8; PROTEIN REG3BETA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL GROWTH; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; GENE OVEREXPRESSION; GENOME ANALYSIS; HISTOPATHOLOGY; INSULIN RELEASE; MALE; MOUSE; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET CELL; PRIORITY JOURNAL; RNA ISOLATION; STREPTOZOCIN DIABETES; UPREGULATION;

ANIMALS; CYTOPROTECTION; DIABETES MELLITUS, EXPERIMENTAL; GENE EXPRESSION REGULATION; GENE TRANSFER TECHNIQUES; GENES; INSULIN; ISLETS OF LANGERHANS; MALE; MICE; MICE, TRANSGENIC; ORGAN SPECIFICITY; PROMOTER REGIONS, GENETIC; PROTEINS; RATS; STREPTOZOCIN; UP-REGULATION;

EID: 79955439452     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00600.2010     Document Type: Article

References (58)

1. Arafat HA, Katakam AK, Chipitsyna G, Gong Q, Vancha AR, Gabbeta J, Dafoe DC. Osteopontin protects the islets and beta-cells from interleukin-1beta-mediated cytotoxicity through negative feedback regulation of nitric oxide. Endocrinology 148: 575-584, 2007.
2. Cabrita MA, Hobman TC, Hogue DL, King KM, Cass CE. Mouse transporter protein, a membrane protein that regulates cellular multidrug resistance, is localized to lysosomes. Cancer Res 59: 4890-4897, 1999.
3. Cardinal JW, Allan DJ, Cameron DP. Differential metabolite accumulation may be the cause of strain differences in sensitivity to streptozotocin- induced beta cell death in inbred mice. Endocrinology 139: 2885-2891, 1998.
4. Chiocchetti A, Orilieri E, Cappellano G, Barizzone N, D'Alfonso S, D'Annunzio G, Lorini R, Ravazzolo R, Cadario F, Martinetti M, Calcaterra V, Cerutti F, Bruno G, Larizza D, Dianzani U. The osteopontin gene β1239A/C single nucleotide polymorphism is associated with type 1 diabetes mellitus in the Italian population. Int J Immunopathol Pharmacol 23: 263-269, 2010.
5. Cui W, De Jesus K, Zhao H, Takasawa S, Shi B, Srikant CB, Liu JL. Overexpression of Reg3alpha increases cell growth and the levels of cyclin D1 and CDK4 in insulinoma cells. Growth Factors 27: 195-202, 2009.
6. De Leon DD, Farzad C, Crutchlow MF, Brestelli J, Tobias J, Kaestner KH, Stoffers DA. Identification of transcriptional targets during pancreatic growth after partial pancreatectomy and exendin-4 treatment. Physiol Genomics 24: 133-143, 2006.
7. De Vos A, Heimberg H, Quartier E, Huypens P, Bouwens L, Pipeleers D, Schuit F. Human and rat beta cells differ in glucose transporter but not in glucokinase gene expression. J Clin Invest 96: 2489-2495, 1995.
8. Desai DM, Adams GA, Wang X, Alfrey EJ, Sibley RK, Dafoe DC. The influence of combined trophic factors on the success of fetal pancreas grafts. Transplantation 68: 491-496, 1999.
9. Devedjian JC, George M, Casellas A, Pujol A, Visa J, Pelegrin M, Gros L, Bosch F. Transgenic mice overexpressing insulin-like growth factor-II in beta cells develop type 2 diabetes. J Clin Invest 105: 731-740, 2000.
10. Finegood DT, Scaglia L, Bonner-Weir S. Dynamics of beta-cell mass in the growing rat pancreas Estimation with a simple mathematical model. Diabetes 44: 249-256, 1995.
11. Gannon M, Shiota C, Postic C, Wright CV, Magnuson M. Analysis of the Cre-mediated recombination driven by rat insulin promoter in embryonic and adult mouse pancreas. Genesis 26: 139-142, 2000.
12. Garcia-Ocana A, Vasavada RC, Takane KK, Cebrian A, Lopez- Talavera JC, Stewart AF. Using beta-cell growth factors to enhance human pancreatic islet transplantation. J Clin Endocrinol Metab 86: 984-988, 2001.
13. George M, Ayuso E, Casellas A, Costa C, Devedjian JC, Bosch F. Beta cell expression of IGF-I leads to recovery from type 1 diabetes. J Clin Invest 109: 1153-1163, 2002.
14. Gigoux V, Clerc P, Sanchez D, Coll MG, Corominola H, Leung- Theung Long S, Penicaud L, Gomis R, Seva C, Fourmy D, Dufresne M. Reg genes are CCK2 receptor targets in ElasCCK2 mice pancreas. Regul Pept 146: 88-98, 2008.
15. Gironella M, Folch-Puy E, LeGoffic A, Garcia S, Christa L, Smith A, Tebar L, Hunt SP, Bayne R, Smith AJ, Dagorn JC, Closa D, Iovanna JL. Experimental acute pancreatitis in PAP/HIP knock-out mice. Gut 56: 1091-1097, 2007.
16. Gross DJ, Weiss L, Reibstein I, van den Brand J, Okamoto H, Clark A, Slavin S. Amelioration of diabetes in nonobese diabetic mice with advanced disease by linomide-induced immunoregulation combined with Reg protein treatment. Endocrinology 139: 2369-2374, 1998.
17. Guo Y, Lu Y, Houle D, Robertson K, Tang Z, Kopchick JJ, Liu YL, Liu JL. Pancreatic islet-specific expression of an IGF-I transgene compensates islet cell growth in growth hormone receptor gene deficient mice. Endocrinology 146: 2602-2609, 2005.
18. Gurr W, Shaw M, Li Y, Sherwin R. RegII is a (beta)-cell protein and autoantigen in diabetes of NOD mice. Diabetes 56: 34-40, 2007.
19. Gurr W, Yavari R, Wen L, Shaw M, Mora C, Christa L, Sherwin RS. A Reg family protein is overexpressed in islets from a patient with new-onset type 1 diabetes and acts as T-cell autoantigen in NOD mice. Diabetes 51: 339-346, 2002.
20. Hervieu V, Christa L, Gouysse G, Bouvier R, Chayvialle JA, Brechot C, Scoazec JY. HIP/PAP, a member of the reg family, is expressed in glucagon-producing enteropancreatic endocrine cells and tumors. Human Pathol 37: 1066-1075, 2006.
21. Hogue DL, Nash C, Ling V, Hobman TC. Lysosome-associated protein transmembrane 4 alpha (LAPTM4 alpha) requires two tandemly arranged tyrosine-based signals for sorting to lysosomes. Biochem J 365: 721-730, 2002.
22. Hosokawa M, Dolci W, Thorens B. Differential sensitivity of GLUT1- and GLUT2-expressing beta cells to streptozotocin. Biochem Biophys Res Commun 289: 1114-1117, 2001.
23. Imai Y, Patel HR, Doliba NM, Matschinsky FM, Tobias JW, Ahima RS. Analysis of gene expression in pancreatic islets from diet-induced obese mice. Physiol Genomics 36: 43-51, 2008.
24. Keim V, Rohr G, Stockert HG, Haberich FJ. An additional secretory protein in the rat pancreas. Digestion 29: 242-249, 1984.
25. Lieu HT, Simon MT, Nguyen-Khoa T, Kebede M, Cortes A, Tebar L, Smith AJ, Bayne R, Hunt SP, Brechot C, Christa L. Reg2 inactivation increases sensitivity to Fas hepatotoxicity and delays liver regeneration post-hepatectomy in mice. Hepatology (Baltimore, Md) 44: 1452-1464, 2006.
26. Liu JL, Coschigano KT, Robertson K, Lipsett M, Guo Y, Kopchick JJ, Kumar U, Liu YL. Disruption of growth hormone receptor gene causes diminished pancreatic islet size and increased insulin sensitivity in mice. Am J Physiol Endocrinol Metab 287: E405-E413, 2004.
27. Liu JL, Cui W. Which gene, Reg2 or Reg3beta, was targeted that affected liver regeneration? Hepatology (Baltimore, Md) 45: 1584-1585; author reply 1585-1586, 2007.
28. Liu JL, Cui W, Li B, Lu Y. Possible roles of reg family proteins in pancreatic islet cell growth. Endocrinol Metab Immune Disord Drug Targets 8: 1-10, 2008.
29. Liu L, Liu JL, Srikant CB. Reg2 protects mouse insulinoma cells from streptozotocin-induced mitochondrial disruption and apoptosis. Growth Factors 28: 370-378, 2010.
30. Lu Y, Herrera PL, Guo Y, Sun D, Tang Z, LeRoith D, Liu JL. Pancreatic-specific inactivation of IGF-I gene causes enlarged pancreatic islets and significant resistance to diabetes. Diabetes 53: 3131-3141, 2004.
31. Lu Y, Ponton A, Okamoto H, Takasawa S, Herrera PL, Liu JL. Activation of the Reg family genes by pancreatic-specific IGF-I gene deficiency and after streptozotocin-induced diabetes in mouse pancreas. Am J Physiol Endocrinol Metab 291: E50-E58, 2006.
32. Madadi G, Dalvi PS, Belsham DD. Regulation of brain insulin mRNA by glucose and glucagon-like peptide 1. Biochem Biophys Res Commun 376: 694-699, 2008.
33. Mallo GV, Fiedler F, Calvo EL, Ortiz EM, Vasseur S, Keim V, Morisset J, Iovanna JL. Cloning and expression of the rat p8 cDNA, a new gene activated in pancreas during the acute phase of pancreatitis, pancreatic development, and regeneration, and which promotes cellular growth. J Biol Chem 272: 32360-32369, 1997.
34. Marselli L, Thorne J, Ahn YB, Omer A, Sgroi DC, Libermann T, Out HH, Sharma A, Bonner-Weir S, Weir GC. Gene expression of purified (beta)-cell tissue obtained from human pancreas with laser capture microdissection. J Clin Endocrinol Metab 93: 1046-1053, 2008.
35. O'Brien BA, Harmon BV, Cameron DP, Allan DJ. Beta-cell apoptosis is responsible for the development of IDDM in the multiple low-dose streptozotocin model. J Pathol 178: 176-181, 1996.
36. Okamoto H, Takasawa S. Recent advances in the Okamoto model: the CD38-cyclic ADP-ribose signal system and the regenerating gene protein (Reg)-Reg receptor system in beta-cells. Diabetes 51, Suppl 3: S462-S473, 2002.
37. Osborn L, Rosenberg MP, Keller SA, Meisler MH. Tissue-specific and insulin-dependent expression of a pancreatic amylase gene in transgenic mice. Mol Cell Biol 7: 326-334, 1987.
38. Päth G, Opel A, Gehlen M, Rothhammer V, Niu X, Limbert C, Romfeld L, Hugl S, Knoll A, Brendel MD, Bretzel RG, Seufert J. Glucose-dependent expansion of pancreatic β-cells by the protein p8 in vitro and in vivo. Am J Physiol Endocrinol Metab 291: E1168-E1176, 2006.
39. Päth G, Opel A, Knoll A, Seufert J. Nuclear protein p8 is associated with glucose-induced pancreatic β-cell growth. Diabetes 53: S82-S85, 2004.
40. Rafaeloff R, Pittenger GL, Barlow SW, Qin XF, Yan B, Rosenberg L, Duguid WP, Vinik AI. Cloning and sequencing of the pancreatic islet neogenesis associated protein (INGAP) gene and its expression in islet neogenesis in hamsters. J Clin Invest 99: 2100-2109, 1997.
41. Rhodes CJ. Type 2 diabetes-a matter of beta-cell life and death? Science 307: 380-384, 2005.
42. Robitaille R, Dusseault J, Henley N, Rosenberg L, Halle JP. Insulinlike growth factor II allows prolonged blood glucose normalization with a reduced islet cell mass transplantation. Endocrinology 144: 3037-3045, 2003.
43. Rosenberg L, Lipsett M, Yoon JW, Prentki M, Wang R, Jun HS, Pittenger GL, Taylor-Fishwick D, Vinik AI. A pentadecapeptide fragment of islet neogenesis-associated protein increases beta-cell mass and reverses diabetes in C57BL/6J mice. Ann Surg 240: 875-884, 2004.
44. Schnedl WJ, Ferber S, Johnson JH, Newgard CB. STZ transport and cytotoxicity: specific enhancement in GLUT2-expressing cells. Diabetes 43: 1326-1333, 1994.
45. Schuit F, Flamez D, De Vos A, Pipeleers D. Glucose-regulated gene expression maintaining the glucose-responsive state of beta-cells. Diabetes 51: S326-S332, 2002.
46. Shalev A, Pise-Masison CA, Radonovich M, Hoffmann SC, Hirshberg B, Brady JN, Harlan DM. Oligonucleotide microarray analysis of intact human pancreatic islets: identification of glucose-responsive genes and a highly regulated TGF(beta) signaling pathway. Endocrinology 143: 3695-3698, 2002.
47. Simon MT, Pauloin A, Normand G, Lieu HT, Mouly H, Pivert G, Carnot F, Tralhao JG, Brechot C, Christa L. HIP/PAP stimulates liver regeneration after partial hepatectomy and combines mitogenic and antiapoptotic functions through the PKA signaling pathway. FASEB J 17:1441-1450, 2003.
48. Song J, Xu Y, Hu X, Choi B, Tong Q. Brain expression of Cre recombinase driven by pancreas-specific promoters. Genesis 48: 628-634, 2010.
49. Stelzl U, Worm U, Lalowski M, Haenig C, Brembeck FH, Goehler H, Stroedicke M, Zenkner M, Schoenherr A, Koeppen S, Timm J, Mintzlaff S, Abraham C, Bock N, Kietzmann S, Goedde A, Toksöz E, Droege A, Krobitsch S, Korn B, Birchmeier W, Lehrach H, Wanker EE. A Human protein-protein interaction network: a resource for annotating the proteome. Cell 122: 957-968, 2005.
50. Takasawa S, Ikeda T, Akiyama T, Nata K, Nakagawa K, Shervani NJ, Noguchi N, Murakami-Kawaguchi S, Yamauchi A, Takahashi I, Tomioka-Kumagai T, Okamoto H. Cyclin D1 activation through ATF-2 in Reg-induced pancreatic beta-cell regeneration. FEBS Lett 580: 585-591, 2006.
51. Tang Z, Yu R, Lu Y, Parlow AF, Liu JL. Age-dependent onset of liver-specific IGF-I gene deficiency and its persistence in old age: implications for postnatal growth and insulin resistance in LID mice. Am J Physiol Endocrinol Metab 289: E288-E295, 2005.
52. Taylor-Fishwick DA, Bowman A, Hamblet N, Bernard P, Harlan DM, Vinik AI. Islet neogenesis associated protein transgenic mice are resistant to hyperglycemia induced by streptozotocin. J Endocrinol 190: 729-737, 2006.
53. Thorens B. A gene knockout approach in mice to identify glucose sensors controlling glucose homeostasis. Pflügers Arch 445: 482-490, 2003.
54. Unno M, Nata K, Noguchi N, Narushima Y, Akiyama T, Ikeda T, Nakagawa K, Takasawa S, Okamoto H. Production and characterization of Reg knockout mice: reduced proliferation of pancreatic beta-cells in Reg knockout mice. Diabetes 51, Suppl 3: S478-S483, 2002.
55. Valera A, Solanes G, Fernandez-Alvarez J, Pujol A, Ferrer J, Asins G, Gomis R, Bosch F. Expression of GLUT-2 antisense RNA in beta cells of transgenic mice leads to diabetes. J Biol Chem 269: 28543-28546, 1994.
56. Vasseur S, Folch-Puy E, Hlouschek V, Garcia S, Fiedler F, Lerch MM, Dagorn JC, Closa D, Iovanna JL. p8 Improves pancreatic response to acute pancreatitis by enhancing the expression of the anti-inflammatory protein pancreatitis-associated protein I. J Biol Chem 279: 7199-7207, 2004.
57. Wicksteed B, Brissova M, Yan W, Opland DM, Plank JL, Reinert RB, Dickson LM, Tamarina NA, Philipson LH, Shostak A, Bernal-Mizrachi E, Elghazi L, Roe MW, Labosky PA, Myers MM Jr, Gannon M, Powers AC, Dempsey PJ. Conditional gene targeting in mouse pancreatic (beta)-cells: analysis of ectopic Cre transgene expression in the brain. Diabetes 59: 3090-3098, 2010.
58. Xu J, Zhang L, Chou A, Allaby T, Belanger G, Radziuk J, Jasmin BJ, Miki T, Seino S, Renaud JM. KATP channel-deficient pancreatic β-cells are streptozotocin resistant because of lower GLUT2 activity. Am J Physiol Endocrinol Metab 294: E326-E335, 2008.